
Shared insight on factors that put patients at risk for glaucoma and how screening can improve early diagnosis and care.
Shared insight on factors that put patients at risk for glaucoma and how screening can improve early diagnosis and care.
Panelists discuss the worldwide gaps in diagnosis of glaucoma and how this negatively affects patient outcomes.
A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.
Experts highlight early detection and the goals of therapy when managing patients with glaucoma.
Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy.
A broad review of therapeutic classes approved for the management of glaucoma and how they may be sequenced.
Experts debate the use of generic agents over branded therapy when managing patients with glaucoma.
Expert perspectives on the factors that inform therapy selection when managing patients with glaucoma.
Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens.
Panelists discuss the role of rho kinase inhibitors in glaucoma management respective to cost, efficacy, and ease of use.
A review of the novel sustained release approach with bimatoprost implants and how this is affecting glaucoma management.
A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option.
Expert panelists review the use of MIGS and other channel procedures in patients with glaucoma.
Shared insight on how the use and sequencing of therapies for glaucoma will evolve in coming years.
Closing out their discussion on glaucoma management, experts share practical advice for care providers and payers alike.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.